Acceptance of pandemic (H1N1) 2009 influenza vaccination by the Australian public
Acceptance of pandemic (H1N1) 2009 influenza vaccination by the Australian public
复制标题
DOI：
10.5694/j.1326-5377.2010.tb03399.x
复制
发表时间：
2010-01-04
影响因子：
11.4
通讯作者：
Butler, Michelle
中科院分区：
文献类型：
--
作者：
Eastwood, Keith;Durrheim, David N.;Butler, Michelle
目的：为了调查澳大利亚公众的期望，关注和愿意接受接种与大流行（H1N1）2009年流感vaccine.Design，设置和参与者：一个计算机辅助的电话采访调查进行了2009年8月20日和9月11日之间，由训练有素的专业采访人员研究有关的问题，疫苗的摄取和感知的安全性。样本包括1155名随机选择的代表性成年人，他们参加了2007年的一项全国性研究，该研究探索了对大流行性流感的认识和看法。主要结果指标：可能接受2009年大流行性流感（H1N1）疫苗接种，与接受相关的因素，以及受访者愿意与邻国分享澳大利亚疫苗。在1155名可能的参与者中，830人（72%）成功接受了采访。研究组中有20%的人（169/830）报告说，他们在2009年大流行期间出现了流感样症状。大多数受访者（645/830，78%）认为2009年大流行（H1N1）是一种轻微的疾病，211/830（25%）认为自己的感染风险增加。接受2009年大流行（H1N1）疫苗接种的意愿很高（556/830，67%），但显著低于2007年调查大流行疫苗接种率时（88%; P
Objective: To investigate the Australian public's expectations, concerns and willingness to accept vaccination with the pandemic (H1N1) 2009 influenza vaccine.Design, setting and participants: A computer-assisted telephone interview survey was conducted between 20 August and 11 September 2009 by trained professional interviewers to study issues relating to vaccine uptake and perceived safety. The sample comprised 1155 randomly selected representative adults who had participated in a 2007 national study exploring knowledge and perceptions of pandemic influenza.Main outcome measures: Likely acceptance of pandemic (H1N1) 2009 vaccination, factors associated with acceptance, and respondents' willingness to share Australian vaccine with neighbouring developing countries.Results: Of 1155 possible participants, 830 (72%) were successfully interviewed. Twenty per cent of the study group (169/830) reported that they had developed influenza-like symptoms during the 2009 pandemic period. Most respondents (645/830, 78%) considered pandemic (H1N1) 2009 to be a mild disease, and 211/830 (25%) regarded themselves as being at increased risk of infection. Willingness to accept pandemic (H1N1) 2009 vaccination was high (556/830, 67%) but was significantly lower than when pandemic vaccination uptake was investigated in 2007 (88%; P